F.D.A.’s Accelerated Drug Approvals Come Under Scrutiny

A drug to prevent preterm birth may provide the next test of the agency’s process for speedily getting drugs on the market, despite limited evidence that some work.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *